2m 2m 2m 2m 2m 2m 2m
Grapefruit USA (GPFT)
OTC
$0.0009-$0.0002 (-14.69%)
Price as of Jun 03, 2026- $1.1MMarket Cap
- 20.00%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Grapefruit USA (GPFT)
$0.0009-$0.0002 (-14.69%)
Key Performance
More- Earnings Score: N/A
- Momentum Score: 69
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
No data found
Peers
Statistics
MoreDay Range
$0.0009
$0.0009
$0.0009
1-Year Range
$0.0003
$0.002
$0.0009
Latest Close$0.0009
Change
+$0.00005 (+4.76%)
Volume120,016
Market Cap$1.1M
Shares Outstanding1.2B
P/E (TTM)-0.12
Diluted EPS (TTM)-$0.008
Enterprise Value$6.5M
Information as of 06/03/2026
Company Profile
Grapefruit USA, Inc
https://www.grapefruitblvd.com$1.1M
Market Cap
-$4.4M
Net Income
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
10866 Wilshire Blvd., Los Angeles, CA, United States, 90024
310 575 1175Grapefruit USA, Inc. operates as a manufacturer and distributor of cannabis products in California. It primarily provides Hourglass, a time release THC+CBD-infused topical cream through online store. Grapefruit USA, Inc. was formerly known as Grapefruit Boulevard Investments, Inc. and changed its name to Grapefruit USA, Inc. in January 2020. Grapefruit USA, Inc. was incorporated in 2017 and is based in Los Angeles, California.
Key Executives
- Daniel J. Yourist
- Bradley J. Yourist
- Chantel Lee
- Beth Jones
- Kenneth J. Biehl
Current Ownership Distribution
- Insiders362.5M (50.53%)
- Other354.9M (49.47%)
- Institutions0 (0.00%)
- Mutual Funds0 (0.00%)